INHIBITION OF REDD1 EXPRESSION FOR THE REDUCTION OF GLUCOCORTICOID-INDUCED SIDE EFFECTS
Glucocorticoids (GC ) have been an integral component of the treatment of leukemias and lymphomas for several decades. Specific cytotoxic effect of GC on transformed lymphoblasts mediates their use at the stage of the remission induction as well as consolidation of treatment. However, the main probl...
Saved in:
| Main Authors: | E. S. Lylova, A. V. Savinkova, E. M. Zhidkova, K. I. Kirsanov, M. G. Yakubovskaya, I. V. Budunova, E. A. Lesovaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2020-12-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/1642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of glucocorticoid-induced REDD1 expression by rapamycin in breast cancer cells
by: D. D. Grigorieva, et al.
Published: (2022-03-01) -
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
by: Gleb Baida, et al.
Published: (2014-12-01) -
Selective glucocorticoid receptor agonists as an alternative to glucocorticoids in the treatment of acute lymphoblastic leukemia: clinical response to glucocorticoids compared with molecular effects <i>in vitro</i>
by: O. A. Vlasova, et al.
Published: (2025-05-01) -
Molecular mechanisms of novel selective glucocorticoid receptor agonist action in breast cancer cells
by: E. M. Zhidkova, et al.
Published: (2024-10-01) -
COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES
by: E. M. Zhidkova, et al.
Published: (2017-12-01)